| Medstar Georgetown University Hospital | |
| 3800 Reservoir Rd, Washington, District Of Columbia 20007 | |
| (202) 784-3000 | |
| Name | Medstar Georgetown University Hospital |
|---|---|
| Type | Acute Care Hospital |
| Location | 3800 Reservoir Rd, Washington, District Of Columbia |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 090004 |
| NPI Number | 1053519470 |
| Organization Name | MGMC, LLC |
| Doing Business As | MEDSTAR GEORGETOWN MEDICAL CENTER |
| Address | 3800 Reservoir Rd Nw, Washington, DC 20007 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 202-444-1400 |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
| NPI Number | 1063541266 |
| Organization Name | GEORGETOWN UNIVERSITY HOSPITAL |
| Address | 3800 Reservoir Rd Nw, Washington, DC 20007 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 202-444-5479 |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
| NPI Number | 1073711065 |
| Organization Name | MEDSTAR GEORGETOWN MEDICAL CENTER, INC |
| Doing Business As | GEORGETOWN UNIVERSITY HOSPITAL PHYSICIANS |
| Address | 3800 Reservoir Rd Nw, General Internal Medicine- Pediatric Pcp, Washington, DC 20007 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 202-444-1400 |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
| NPI Number | 1245438316 |
| Organization Name | MGMC, LLC |
| Doing Business As | MEDSTAR GEORGETOWN MED CENTER- PSYCHIATRY |
| Address | 3800 Reservoir Rd Nw, Dept Of Psychiatry, Washington, DC 20007 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 202-444-1400 |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
| NPI Number | 1316137201 |
| Organization Name | MEDSTAR GEORGETOWN MEDICAL CENTER, INC |
| Doing Business As | GEORGETOWN UNIVERSITY HOSPITAL PHYSICIANS |
| Address | 3800 Reservoir Rd Nw, General Internal Medicine- Adult Pcp, Washington, DC 20007 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 202-444-1400 |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
| NPI Number | 1417134156 |
| Organization Name | GEORGETOWN UNIVERSITY HOSPITAL |
| Address | 3800 Reservoir Rd Nw, Washington, DC 20007 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 202-444-3690 |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
| NPI Number | 1518391267 |
| Organization Name | MEDSTAR GEORGETOWN UNIVERSITY HOSPITAL |
| Address | 3800 Reservoir Rd Nw, Bles Building, Washington, DC 20007 |
| Hospital Type | General Acute Care Hospital - Rural |
| Phone Number | 202-444-5592 |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
| NPI Number | 1538367750 |
| Organization Name | MGMC, LLC |
| Doing Business As | MEDSTAR GEORGETOWN MED CENTER |
| Address | 3800 Reservoir Rd Nw, General Internal Medicine- Pediatric Pcp, Washington, DC 20007 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 202-444-1400 |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
| NPI Number | 1730387945 |
| Organization Name | MGMC, LLC |
| Doing Business As | MEDSTAR GEORGETOWN MEDICAL CENTER |
| Address | 3800 Reservoir Rd Nw, Midwives, Washington, DC 20007 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 202-444-1400 |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
| NPI Number | 1801094024 |
| Organization Name | MGMC, LLC |
| Doing Business As | MEDSTAR GEORGETOWN MED CENTER |
| Address | 3800 Reservoir Rd Nw, General Internal Medicine- Adult Pcp, Washington, DC 20007 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 202-444-1400 |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
| NPI Number | 1861690083 |
| Organization Name | MGMC, INC |
| Doing Business As | GEORGETOWN UNIVERSITY HOSPITAL PHYSICIANS |
| Address | 3800 Reservoir Rd Nw, General Care, Washington, DC 20007 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 202-444-1400 |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
| NPI Number | 1982802328 |
| Organization Name | MGMC, LLC |
| Doing Business As | MEDSTAR GEORGETOWN MEDICAL CENTER |
| Address | 3800 Reservoir Rd Nw, Department Of Radiation Medicine, Washington, DC 20007 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 202-444-1400 |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.
An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.
› Verified 1 days ago
George Washington Univ Hospital Acute Care Hospital Location: 900 23rd St Nw, Washington, District Of Columbia 20037 Phone: (202) 716-4605 | |
Howard University Hospital Acute Care Hospital Location: 2041 Georgia Ave Nw, Washington, District Of Columbia 20060 Phone: (202) 745-6100 | |
Medstar Georgetown University Hospital Acute Care Hospital Location: 3800 Reservoir Rd, Washington, District Of Columbia 20007 Phone: (202) 784-3000 | |
Sibley Memorial Hospital Acute Care Hospital Location: 5255 Loughboro Rd Nw, Washington, District Of Columbia 20016 Phone: (202) 537-4680 | |
United Medical Center Acute Care Hospital Location: 1310 Southern Avenue Se, Washington, District Of Columbia 20032 Phone: (202) 574-6611 | |
Medstar Washington Hospital Center Acute Care Hospital Location: 110 Irving Street Nw, Washington, District Of Columbia 20010 Phone: (202) 877-7000 |